BURBANK, CA--(Marketwire - Sep 8, 2011) - Imaging3T, Inc. (OTCBB: IMGG), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, today announced that the company has submitted their Imaging Protocol Proposal to the FDA for review and to schedule a face-to-face meeting with the FDA and Imaging3's Submission Team.